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Abstract
Background: Maternal infection during pregnancy may be a risk factor for epilepsy in offspring. Use of antibiotics is a valid
marker of infection.
Methodology/Principal Findings: To examine the relationship between maternal infection during pregnancy and risk of
childhood epilepsy we conducted a historical cohort study of singletons born in northern Denmark from 1998 through 2008
who survived $29 days. We used population-based medical databases to ascertain maternal use of antibiotics or hospital
contacts with infection during pregnancy, as well as first-time hospital contacts with a diagnosis of epilepsy among
offspring. We compared incidence rates (IR) of epilepsy among children of mothers with and without infection during
pregnancy. We examined the outcome according to trimester of exposure, type of antibiotic, and total number of
prescriptions, using Poisson regression to estimate incidence rate ratios (IRRs) while adjusting for covariates. Among
191 383 children in the cohort, 948 (0.5%) were hospitalised or had an outpatient visit for epilepsy during follow-up,
yielding an IR of 91 per 100 000 person-years (PY). The five-year cumulative incidence of epilepsy was 4.5 per 1000 children.
Among children exposed prenatally to maternal infection, the IR was 117 per 100 000 PY, with an adjusted IRR of 1.40 (95%
confidence interval (CI): 1.22–1.61), compared with unexposed children. The association was unaffected by trimester of
exposure, antibiotic type, or prescription count.
Conclusions/Significance: Prenatal exposure to maternal infection is associated with an increased risk of epilepsy in
childhood. The similarity of estimates across types of antibiotics suggests that processes common to all infections underlie
this outcome, rather than specific pathogens or drugs.
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Introduction
Epilepsy is the most common serious neurologic disorder of
childhood [1–3]. Before the age of 15 years, 1.0%–1.7% of all
children will have at least one unprovoked seizure and up to 0.8%
will have repeated seizures [2]. The incidence of childhood
epilepsy is highest in the first year of life – about 150 per 100 000
person-years (PY), falling to around 50 per 100 000 PY after age 9
years [2].
The aetiology of epilepsy is poorly understood [1,2], with no
known risk factor in many cases [1,4,5]. Generalised epilepsies
often can be traced infection [2]. In particular, insults acting
during the prenatal and to single-gene mutations or chromosomal
abnormalities, while partial epilepsies are frequently triggered by
external insults to the central nervous system, including brain
injury and central nervous system neonatal period are thought to
contribute to the aetiology of some epilepsies [1,2,6–8].
Observation of a seasonal pattern, i.e. an excess of births during
winter months among children who develop epilepsy [9,10], led to
thesuggestionthatprenatalexposuretomaternalinfectionmaybea
risk factor. In a Canadian population-based study of 648 new cases
of epilepsy among 124 207 children born in 1986–2000 and
followed for a median of 8.5 years, any maternal infection during
pregnancy (method of measurement unspecified) was associated
with a 1.0–1.6-fold increase in risk of childhood epilepsy [8]. In a
previous Danish study, maternal self-reported history of cystitis,
pyelonephritis, vaginal yeast infection, and/or symptoms of
infection (diarrhoea, coughs) during pregnancy was associated with
a 1.2- to 2.6-fold increased risk of epilepsy among offspring [11].
Risk varied by type of infection and was the highest for self-reported
vaginal yeast infection (incidence rate ratio (IRR)=2.6 (95% CI:
1.4–4.6)) and pyelonephritis (IRR=2.3 (95% CI: 1.2–4.7)) [11].
We conducted a large population-based historical cohort study
in Denmark to examine the relationship between maternal
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childhood epilepsy in singletons born from 1998 through 2008.
In contrast to the earlier study from Denmark that relied on self-
report, we used routinely recorded markers of infection –
prescription and hospitalisation records – to examine the role of
the type and severity of infection and trimester of exposure.
Furthermore, we examined whether the association between
infections and epilepsy differed by maternal history of epilepsy.
Methods
Setting
We conducted this study in the Central and the Northern
Regions of Denmark, with a combined population of 1.8 million
persons. The Danish National Health Service provides tax-
supported healthcare, with free access to hospital-based and
primary medical care and partial reimbursement for the costs of
most prescribed drugs, including antibiotics.
Study population
From the Danish Medical Birth Registry [12], we retrieved
birth records of all singletons born in the two regions during the
1998–2008, who survived at least 29 days [11]. We imposed this
survival requirement to allow time for diagnostic work-up. The
Birth Registry contains computerised records of all births in
Denmark since 1973. Data are collected by midwives or physicians
overseeing the deliveries and include the civil registration numbers
of the mother and the newborn, permitting linkage to maternal
records.
Data linkage
The unique ten-digit civil registration number, assigned to all
residents of Denmark by the Central Office of Civil Registration
since 1968 [13], is used in all Danish registries, permitting
unambiguous individual-level linkage of data from all sources used
in this study.
Maternal infection during pregnancy
We measured prenatal exposure to maternal infection by
ascertaining maternal antibiotic prescriptions and maternal history
of inpatient hospital stays or outpatient/emergency visits with a
diagnosis of infection. The Northern and Central Regions of
Denmark are served by pharmacies equipped with electronic
accounting systems used primarily to secure reimbursement from
the National Health Service. Prescription information, including
the customer’s civil registration number, the type and amount of
drug prescribed according to the Anatomical Therapeutic
Chemical (ATC) classification system, and the date of dispensa-
tion, is transferred from the pharmacies to the Aarhus University
Prescription Database [14]. All filled reimbursed prescriptions are
included in this database, including prescriptions from doctors
working in hospitals or private practising doctors. We used this
database to identify all prescriptions for systemic antibiotics and
systemic or vaginal antifungals, filled from the estimated date of
conception until birth (see Appendix S1 for relevant ATC codes).
Because drugs administered during hospitalisations do not
generate records in the prescription database, we retrieved from
the Danish National Registry of Patients (DNRP), maternal
diagnoses of infection recorded between the estimated conception
date and birth. The DNRP has tracked hospitalisations since 1977
and outpatient and emergency room visits at all public hospitals in
Denmark since 1995 [15]. The recorded data include patients’
civil registration numbers, dates of admission and discharge, and
up to 20 diagnoses, classified according to the International
Classification of Diseases, 10th revision (ICD-10). We included all
hospital contacts (emergency and inpatient admissions, and
outpatient visits) with a diagnosis of infection. The relevant
ICD-10 codes are listed in Appendix S1. Newborns whose
mothers had a record of either an antibiotic prescription filled at
a community pharmacy or a hospital visit with a diagnosis of
infection were considered prenatally exposed to a maternal
infection. Newborns without this maternal history were used as
the reference group for all comparisons in this study.
We categorised prescribed antibiotics into penicillins, pivme-
cillinam, sulfamethizole and/or trimethoprim, macrolides, anti-
fungals and all other antibiotics. In Denmark, pivmecillinam and
sulfamethizole and/or trimethoprim are used predominantly for
urinary tract infections and penicillin is used primarily for
respiratory infections [16].
Epilepsy
As nearly all children with epilepsy in Denmark are expected to
have a hospital contact (admission or outpatient clinic visit) [17],
we used the DNRP to identify children with this diagnosis. We
defined the study outcome as a first-time hospitalisation or an
outpatient visit with a diagnosis of epilepsy recorded in the DNRP
during the follow-up period. We also ascertained children’s
prescriptions for antiepileptic drugs using the ATC code N03.
We did not use prescription records to define childhood epilepsy
because physicians may refrain from or postpone antiepileptic
drug treatment in about 15% of new-onset cases [18].
Covariates
We identified potential confounding factors based on our a priori
knowledge on potential risk factors for childhood epilepsy that
could also be associated with maternal infection. We defined
maternal epilepsy [19] as a prescription for an antiepileptic drug
filled at any time from conception until giving birth or a ICD-10
code for epilepsy recorded in DNRP (See Appendix S1 for
relevant ATC and ICD-10 codes). We similarly defined maternal
diabetes as a prescription for an antidiabetic filled at any time
before or during gestation of a child in the study population or an
ICD-10 code for diabetes [8,19] recorded in the DNRP (See
Appendix S1 for relevant ATC and ICD-10 codes). From the
DNRP we obtained history of maternal hospitalisation with
preeclampsia or eclampsia [8,20] during the relevant pregnancy.
From the Medical Birth Registry, we obtained information on
birth order [8], maternal age [8,19], self-reported smoking during
pregnancy [8], caesarean delivery [8], gestational age [7,21], birth
weight [7], and Apgar score at five minutes [6,22]. Furthermore,
because congenital malformations are associated with an increased
risk of epilepsy [23,24] and may also be associated with maternal
use of antibiotics [25], we ascertained from the DNRP all
diagnoses of congenital malformations detected within the first
year of life among the children in the study population. See
Appendix S1 for relevant codes.
Statistical analysis
We followed each child from the 29
th day of life until the date of
the first epilepsy-related hospitalisation/outpatient contact, emi-
gration, death, or 1 January 2009, whichever came first. We
computed incidence rates (IR) of epilepsy overall and according to
prenatal exposure to maternal infection as defined in this study
(overall and in each trimester). We computed IRs for the first,
second, third, fourth and subsequent years of life and estimated the
one- and five-year cumulative incidence of epilepsy using the
formula (cumulative incidence=1-exp(-IR6t), where t indicates
time), assuming constant average IR [26]. We categorised
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dispensed during pregnancy (1, 2, 3, .3), as a marker of severity,
to evaluate a potential dose-response pattern, using the x
2 test for
trend. In addition to examining potential variation according to
maternal history of epilepsy, we examined whether the association
between maternal infection and epilepsy varied according to a
child’s sex, birth order, maternal age at delivery, smoking during
pregnancy, maternal history of diabetes or preeclampsia/eclamp-
sia (one variable), caesarean delivery, gestational age, being small
for gestational age (SGA) at term, and Apgar score at five minutes.
We used Poisson regression to estimate IRRs for epilepsy-related
hospitalisations/outpatient and emergency contacts associated
with maternal infection, while adjusting for birth order(firstborn,
yes/no), calendar year of birth (annual indicator for each year
between 1998 and 2008 and in the time intervals 1998–2002 vs.
2003–2008 for analyses restricted to children of mothers with
epilepsy), maternal age (#20, 21–34, $35 years), smoking in
pregnancy (yes/no), history of epilepsy (yes/no), or history of
diabetes or preeclampsia/eclampsia (yes/no). In an additional
analysis we estimated IRRs for partial epilepsy and generalised
epilepsy separately. Partial epilepsy was defined as an ever-
recorded diagnosis of partial epilepsy and no diagnosis of
generalised epilepsy. Generalised epilepsy was defined as an
ever-recorded diagnosis of generalised epilepsy in the absence of a
history of partial epilepsy. Children with diagnoses for both types
of epilepsy and those who only had unspecified epilepsy were
excluded from this analysis.
In a series of sensitivity analyses, we examined the effect of
additional adjustment for low birth weight (,2500 g) and preterm
birth (,37 weeks), the effect of restriction to children without
congenital malformations, and the effect of using dispensing of
antiepileptic drugs to define the outcome of epilepsy in children.
We used SAS version 9.02 (SAS Institute Inc., Cary, North
Carolina, USA). The study was approved by the Danish Registry
Board (Record no. 2002–41–1820).
Role of the funding source
The funding source had no role in the study design, data
collection, data analysis, data interpretation, or writing of the
paper. All authors had full access to all the data in the study and
HTS had the final responsibility for the decision to submit for
publication.
Results
Among 191 383 eligible singleton births, 57 826 (30%)
newborns were prenatally exposed to maternal infection. Maternal
antibiotic use was recorded for 55 743 (29%) newborns and
maternal hospital contacts with infection were recorded for 6292
(3%). In total 4209 (2%) children had a record of a maternal
prescription for antibiotics and of a hospital contact with an
infection during the gestation. The children were followed for a
median of 5 years and up to 11 years. Cumulatively, there were
1 041 843 PY of observation. Table 1 presents baseline charac-
teristics of pregnancies according to maternal infection status in
pregnancy.
During the follow-up, 948 infants had a hospital contact for
epilepsy (718 inpatient admissions (76%) and 230 outpatient clinic
Table 1. Descriptive data on 191 383 singleton births in the Northern and Central Regions of Denmark during 1998–2008,
according to maternal use of antibiotics or hospitalisations with infections during pregnancy.
Prenatal Exposure to Infection Total
No Yes
N% N % N%
Total 133 557 70?0 57 826 30?0 191 383 100?0
Maternal prescription for antibiotics during pregnancy 0 0 55 743 96?4 55 743 29?1
Inpatient or outpatient hospital visit with infection 0 0 6 292 10?96 2 9 2 3 ?3
Maternal age at delivery, years
#20 2 884 2?2 1 980 3?44 8 6 4 2 ?5
21–34 109 933 82?3 47 074 81?4 157 007 82?0
$35 20 740 15?5 8 772 15?2 29 512 15?4
Firstborn 75 043 56?2 35 982 62?2 111 025 58?0
Maternal smoking in pregnancy 22 526 16?9 12 851 22?2 35 377 18?5
Maternal history of epilepsy 1 289 1?0 788 1?42 0 7 7 1 ?1
Maternal history of diabetes 1 093 0?8 854 1?51 9 4 7 1 ?0
Preeclampsia in relevant pregnancy 3 194 2?4 1 675 2?94 8 2 4 2 ?5
Cesarean delivery 21 261 15?9 10 282 17?8 31 543 16?5
Sex
Girl 65 119 48?8 28 139 48?7 93 258 48?7
Boy 68 438 51?2 29 687 51?3 98 125 51?3
Birth weight ,2500 grams 4 251 3?2 2 001 3?56 2 5 2 3 ?3
Gestation ,37 weeks 6 253 4?7 3 046 5?39 2 9 9 4 ?9
Apgar ,7 at 5 minutes 784 0?6 347 0?61 1 3 1 0 ?6
Malformation 4 828 3?6 2 244 3?97 0 7 2 3 ?7
doi:10.1371/journal.pone.0030850.t001
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The IR was highest in the first year of life (193 per 100 000 PY
based on 332 epilepsy cases). IRs (per 100 000 PY) during the 2nd,
3rd, and 4th–11th years of life were 96, 68, and 64, respectively.
The one-year cumulative incidence of epilepsy was 1?9 per 1000
children; the five-year cumulative incidence was 4?5 per 1000
children.
The IR for epilepsy was higher among singletons prenatally
exposed to maternal infection (overall IR=117 per 100 000 PY);
adjusted incidence rate ratio (IRR)=1.40 (95% CI: 1.22–1.61)
compared with unexposed singletons. IRs were similar among
children prenatally exposed to different subgroups of antibiotics
(Table 2). The IRR of epilepsy did not differ substantially either by
trimester of exposure or by the length of follow-up (Table 3). The
adjusted IRR associated with maternal hospital admissions with
infection was 1.36 (95% CI: 0.97–1.90). We observed a higher risk
of epilepsy with an increasing total number of antibiotic
prescriptions, suggesting a dose-response pattern (Table 3). A
maternal record of an antifungal prescription was present for
19 019 (9.9%) of the children, with 93% of cases associated with
maternal use of vaginal antifungals. The incidence rate of epilepsy
among children exposed to maternal antifungals was 88 per
100 000 PY, and the associated adjusted IRR was 0.98 (95% CI:
0.78–1.20) compared with the unexposed. All estimates remained
virtually unchanged after additional adjustment for preterm birth
and low birth weight (data not shown).
In the analysis of epilepsy types, adjusted IRRs associated with
prenatal exposure to maternal infection were 1.53 (95% CI: 1.18–
1.98) for partial epilepsy and 1.39 (95% CI: 1.09–1.79) for
generalised epilepsy. Among the 948 children diagnosed with
epilepsy, 612 (65%) had a prescription for an antiepileptic drug.
The IR of antiepileptic-drug-treated epilepsy was 78 per 100 000
PY among children prenatally exposed to either maternal
antibiotic treatment or maternal hospitalisation with infection.
The corresponding IR was 51 among the unexposed children.
This yielded a crude IRR of 1.51 (95% CI: 1.28–1.78) and an
adjusted IRR of 1?47 (95% CI: 1.24–1.73).
Among children whose mothers had a history of epilepsy, the IR
for epilepsy was 260 per 100 000 PY and the adjusted IRR
associated with prenatal exposure to maternal infection was 2.61
(95% CI: 1.15–5.92). The association between maternal infection
and epilepsy did not vary according to any other perinatal
characteristics examined and did not change when the analyses
were restricted to children without congenital malformations (data
not shown; estimates are available from the authors upon request).
Discussion
In this population-based historical cohort study, we found a
40% increased risk of epilepsy associated with prenatal exposure to
maternal infection. This association could be caused by the
infection itself, its antecedents or consequences, or by antibiotic
treatment. However, the similar magnitude of IR observed for
different types of antibiotics argues against the role of specific types
of infections or specific treatments. Our study extends the findings
by Sun et al,. based on data from the Danish National Birth Cohort
(1996–2002) [27], that maternal infections of different types,
measured by self-report collected twice during pregnancy and
additionally at 6 months after delivery, were associated with
epilepsy in offspring [11]. While the Sun et al. study examined a
nationwide sample of births in Denmark in which participation
was based on self-selection and our study encompassed all births in
the two northern regions of Denmark, we cannot rule out at least
some overlap between the two study populations during 1999–
2002. Given the similarity of the settings, the overall consistency of
results is reassuring. Our study confirmed, using objective
measures of infection, the overall association, found earlier,
between maternal systemic infection and risk of epilepsy regardless
of infection site. However, we found no association with antifungal
treatment, while Sun et al., found that self-reported maternal
vaginal yeast infection was associated with more than a two-fold
increased risk of childhood epilepsy. Given that most antifungals
are administered locally, our finding supports the argument that
systemic effects of disease or treatment underlie the association
with epilepsy in offspring.
Furthermore, our finding is in line with two previous studies
showing an association between intrapartum fever and
increased risk of neonatal seizures [28,29]. Another recent
study based on the Danish National Birth Cohort found no
association between self-reported elevated maternal body
temperature (due to fever or sauna use) during pregnancy and
increased risk of epilepsy in offspring [30]. However, children
with prenatal exposure to more than two maternal fever
episodes, maternal fever with urinary symptoms, or maternal
fever of 39.0uC or did have an increased risk of epilepsy –
suggesting that the underlying causes of fever rather than
elevated temperature play a role [30]. Recently it has been
suggested that inflammation may be involved in the mechanism
linking fever and epilepsy [31]. Experimental studies in rodents
have shown that inflammatory reactions in the brain can
enhance neuronal excitability [32], and anti-inflammatory
Table 2. Incidence rates of epilepsy (per 100 000 person-years) and adjusted incidence rate ratios overall and according to type of
prenatal antibiotic exposure within 30 days before conception or during pregnancy.
Antibiotic use Births, N
Epilepsy
cases, N Person-years Incidence rate
Adjusted* incidence
rate ratio (95% CI)
None 131 307 587 730 657 8?01 ?0
Any 60 076 361 311 176 11?61 ?40 (1?22–1?61)
Pivmecillinam 17 756 106 76 527 13?91 ?55 (1?25–1?93)
Penicillin V 27 150 177 145 012 12?21 ?56 (1?30–1?87)
Other penicillins 12 259 79 65 755 12?01 ?46 (1?15–1?87)
Sulfonamides/trimethoprim 12 748 83 67 782 12?21 ?42 (1?12–1?82)
Macrolides 5 847 46 33 697 13?71 ?61 (1?15–2?25)
*Adjusted for birth year, birth order (1, 2+), maternal age (#20, 21–34, $35), smoking in pregnancy (yes/no), maternal history of epilepsy, and maternal history of
diabetes or preeclampsia/eclampsia.
doi:10.1371/journal.pone.0030850.t002
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are key players in the modulation of neuronal excitability, as
well as in leukocyte recruitment, and inflammatory central
nervous system infections [31], yet little is known about their
role in the pathogenesis of epilepsy. It is possible that maternal
cytokine production in response to an infection during
pregnancy induces foetal neurological injury [29]. Our finding
of a nearly threefold increased IRR for epilepsy among children
born to mothers with epilepsy suggested that infants genetically
predisposed to epilepsy may be more susceptible to inflamma-
tory reactions.
Strengths and limitations of the study
We conducted a large study in a well-defined population and
within a uniform health care system. Our use of population-based
registries permitted virtually complete follow-up for both exposure
and outcome [33]. A potential study weakness is our reliance on
hospital diagnoses of epilepsy, of which an estimated 81% (95%
CI: 75%–87%) can be confirmed by a medical-chart diagnosis
according to the stringent criteria in the International League
against Epilepsy classification [17]. Presence of false positive
records of epilepsy in registry data may partially explain the
relatively low prevalence of antiepileptic drug use among mothers
and offspring with an epilepsy diagnosis (between 65% and 70% in
our study vs. 85% reported in other countries [18,34]). At the
same time, children in Denmark with conditions such as rolandic
epilepsy or infantile spasms are not treated universally with
antiepileptic drugs [35]. However, our study yielded similar
relative risk estimates for partial epilepsy and generalised epilepsy.
As any diagnostic misclassification is unlikely to differ by preceding
maternal infection status, the statistical expectation for the
direction of a resulting bias is towards the null, unless an upward
bias arises by chance [36].
We based our study on the assumption that use of antibiotics is a
valid marker for infection since infections are the specific
indication for antibiotics. A study in Denmark of 7606 patients
who were prescribed antibiotics by one of 602 general practition-
ers found that only 0.7% received antibiotic prescription
prophylactically, and only 0.6% of patients received such
prescription for unknown or not specified infections. In the
remaining 98.7% of the patients, a prescription to an antibiotic
could be traced to a specific infection diagnosis [37]. A Swedish
study in patients who underwent inguinal hernia repair found that
the risk of antibiotic treatment during the post-surgical period was
of the same order of magnitude as infection rates reported in the
Swedish Hernia Register and review studies and concluded that
surveillance of postoperative antibiotic use may be considered as a
resource-saving surrogate marker for surgical-site infections [38].
We do not know whether the pregnant women in our study
actually took the drugs prescribed to them. We speculate that
compliance was likely to be high, particularly for those redeeming
more than one prescription, since financial and time expenditures
were involved in obtaining the medications. Any misclassification
of medication use due to noncompliance would be expected to
attenuate our relative estimates because it is likely unrelated to
diagnosis of epilepsy in children.
In conclusion, our data showed a slightly increased risk of
epilepsy associated with prenatal exposure to maternal infections.
Similar risk estimates for different categories of antibiotics suggest
that the increased risk stems from the consequences of infection
rather than the type of infection or drug.
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Table 3. Crude and adjusted incidence rate ratios with 95% confidence intervals (CI) for epilepsy diagnosed in the entire follow-up
period or during first year of life according to maternal infection during the entire follow-up period and in the first year of life,
compared with non-use.
Entire follow-up period First year of life
Crude incidence rate
ratio (95% CI)
Adjusted* incidence
rate ratio (95% CI)
Crude incidence rate
ratio (95% CI)
Adjusted* incidence
rate ratio (95% CI)
Antibiotic prescription
Anytime during pregnancy 1?46 (1?27–1?66) 1?40 (1?22–1?61) 1?46 (1?17–1?83) 1?44 (1?14–1?81)
First trimester 1?67 (1?39–2?00) 1?58 (1?32–1?90) 1?47 (1?07–2?02) 1?41 (1?02–1?96)
Second trimester 1?44 (1?20–1?72) 1?37 (1?14–1?64) 1?63 (1?23–2?16) 1?57 (1?17–2?10)
Third trimester 1?48 (1?23–1?78) 1?41 (1?17–1?71) 1?45 (1?07–1?97) 1?41 (1?03–1?94)
Hospital diagnosis of infection 1?51 (1?09–2?10) 1?36 (0?97–1?90) 1?36 (0?78–2?39) 1?30 (0?74–2?29)
Number of antibiotic prescriptions during pregnancy
11 ?38 (1?18–1?62) 1?34 (1?14–1?57) 1?40 (1?08–1?82) 1?40 (1?07–1?83)
21 ?34 (1?04–1?73) 1?31 (1?01–1?70) 1?49 (0?99–2?22) 1?50 (1?00–2?25)
32 ?11 (1?50–2?96) 1?97 (1?39–2?79) 1?56 (0?82–2?93) 1?40 (0?72–2?73)
.32 ?01 (1?32–3?08) 1?81 (1?17–2?80) 2?00 (1?03–3?90) 1?77 (0?87–3?59)
P for linear trend 0?02 0?07 0?30 ?6
*Adjusted for birth year, birth order (1, 2+), maternal age (#20, 21–34, $35), smoking in pregnancy (yes/no), maternal, history of epilepsy, and maternal history of
diabetes or preeclampsia/eclampsia.
doi:10.1371/journal.pone.0030850.t003
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